MarketCapExport financials
Advanced Micro Devices (AMD)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Advanced Micro Devices Financial Ratios 2025-2007 | AMD
Brief overview of Advanced Micro Devices's multiples and efficiency
Current figures are compared with the company's own five-year history for 2021–2025.
Key multiples at the end of the period are P/E 76.02x (median 93.65x), EV/EBITDA 37.19x (median 49.5x), P/S 9.51x (median 9.1x). The multiple basket looks neutral against its history, differing from median levels by roughly 0%.
Earnings yield calculated as 1/P/E is about 1.3%, showing current profit per unit of share price.
Current measures of operating quality are ROE 6.9%, ROA 5.6%, ROCE 5.9%. Profitability sends a weak positive signal and leaves the business sensitive to cost or demand pressure.
PEG is 1.35x. Price relative to expected growth is in a moderate range.
The cash conversion cycle increased 65.5 days to 152.1 days, weakening working-capital efficiency.
Conclusion
Advanced Micro Devices trades near its familiar ratio range. A new earnings or profitability trend is needed to change the view.
Annual Financial Ratios Advanced Micro Devices
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.0 | 109.4 | 319.8 | 93.6 | 47.3 | 40.2 | 161.8 | 63.7 | -384.3 | -17.8 | -2.5 | -5.0 | -31.0 | -1.8 | 10.0 | 12.3 | 10.9 | -1.3 | - | |
P/S |
9.5 | 7.0 | 12.0 | 5.2 | 9.1 | 10.2 | 8.2 | 3.3 | 2.4 | 2.1 | 0.4 | 0.4 | 0.5 | 0.4 | 0.7 | - | - | - | - |
EPS |
2.7 | 1.0 | 0.5 | 0.8 | 2.6 | 2.1 | 0.3 | 0.3 | -0.0 | -0.6 | -0.8 | -0.5 | -0.1 | -1.6 | 0.7 | 0.7 | 0.5 | -5.2 | - |
EV (Enterprise Value) |
324 B | 176 B | 269 B | 119 B | 147 B | 98.5 B | 56.9 B | 23.7 B | 14.5 B | 10.5 B | 4.37 B | 4.78 B | 5.5 B | 5 B | 7.39 B | 5.18 B | 1.53 B | 3.19 B | -1.43 B |
EBITDA per Share |
2.6 | 1.45 | 0.52 | 1.09 | 3.25 | 1.34 | 0.604 | 0.572 | 0.272 | -0.298 | -0.401 | -0.0169 | 0.448 | -1.08 | 0.681 | 1.73 | 2.66 | -1.21 | - |
EV/EBITDA |
76.9 | 74.7 | 319.7 | 69.7 | 37.2 | 65.5 | 80.0 | 35.3 | 49.5 | -36.3 | -9.2 | -248.8 | 10.9 | -4.5 | 12.2 | 4.2 | 0.9 | -4.4 | - |
PEG |
1.35 | 1.69 | 10.58 | 1.49 | 1.25 | 9.66 | -41.76 | 0.06 | -4.08 | -0.62 | 0.04 | 0.01 | -0.33 | 0.01 | 1.71 | - | - | - | - |
P/B |
4.3 | 2.6 | 4.0 | 1.8 | 12.0 | 11.2 | 19.5 | 17.0 | 21.3 | 21.3 | -4.0 | 10.7 | 4.7 | 3.9 | 3.1 | 1.2 | 0.4 | - | - |
P/CF |
42.7 | 59.0 | 163.8 | 34.7 | 42.5 | 93.4 | 199.9 | -166.4 | -125.6 | 681.5 | -5.2 | -10.4 | -11.1 | -4.4 | 37.1 | -14.0 | 6.7 | -6.0 | - |
ROE % |
6.88 | 2.85 | 1.53 | 2.41 | 42.18 | 42.66 | 12.06 | 26.62 | -5.54 | -119.47 | 160.19 | -215.51 | -15.26 | -219.89 | 30.88 | 46.50 | 45.22 | -2437.80 | - |
ROA % |
5.64 | 2.37 | 1.26 | 1.95 | 25.46 | 27.78 | 5.66 | 7.40 | -0.93 | -14.97 | -21.40 | -10.70 | -1.91 | -29.58 | 9.91 | 9.49 | 3.23 | - | - |
ROCE % |
5.86 | 3.30 | 0.72 | 2.31 | 48.66 | 23.45 | 12.40 | 17.07 | 5.64 | -19.34 | -28.61 | -9.28 | 3.75 | -40.72 | 14.65 | 83.71 | 102.47 | -1539.37 | - |
Current Ratio |
- | - | - | - | - | - | 1.9 | 1.8 | 1.7 | 1.9 | 1.7 | 1.9 | 1.8 | 1.6 | 1.8 | - | - | - | - |
DSO |
65.9 | 74.4 | 68.0 | 52.8 | 53.0 | 73.4 | 100.8 | 69.6 | 31.5 | 26.6 | 48.7 | 54.2 | 57.3 | 42.4 | 51.1 | - | - | - | - |
DIO |
142.5 | 140.9 | 121.3 | 80.4 | 72.0 | 80.2 | 92.8 | 76.6 | 73.1 | 83.7 | 85.0 | 68.2 | 97.2 | 49.0 | 47.9 | - | - | - | - |
DPO |
56.3 | 63.2 | 67.9 | 53.6 | 38.4 | 49.1 | 93.4 | 75.6 | 40.4 | 49.1 | 35.0 | 41.3 | 57.0 | 24.2 | 54.3 | - | - | - | - |
Operating Cycle |
208.4 | 215.3 | 189.3 | 133.2 | 125.0 | 153.6 | 193.6 | 146.2 | 104.6 | 110.3 | 133.8 | 122.4 | 154.5 | 91.4 | 99.0 | - | - | - | - |
Cash Conversion Cycle |
152.1 | 152.2 | 121.4 | 79.7 | 86.6 | 104.5 | 100.2 | 70.6 | 64.2 | 61.2 | 98.8 | 81.1 | 97.4 | 67.2 | 44.6 | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios Advanced Micro Devices
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
1.4 | 0.85 | 0.76 | 0.54 | 0.44 | 0.48 | 0.16 | 0.08 | - | 0.18 | 0.02 | -0.09 | - | 0.04 | 0.28 | 0.56 | - | 0.76 | 0.58 | 0.46 | 1.48 | 0.33 | 0.13 | 0.14 | 0.15 | 0.11 | 0.03 | 0.01 | 0.04 | 0.1 | 0.12 | 0.08 | -0.02 | 0.06 | -0.04 | -0.04 | -0.06 | -0.5 | 0.09 | -0.14 | -0.13 | -0.25 | -0.23 | -0.23 | -0.47 | 0.02 | -0.05 | -0.03 | 0.12 | 0.06 | -0.1 | -0.19 | -0.63 | -0.21 | 0.05 | -0.8 | -0.24 | 0.13 | 0.08 | 0.71 | -0.17 | -0.06 |
EBITDA per Share |
1.89 | 1.24 | 1.82 | 0.62 | 0.85 | - | - | 0.41 | - | 0.55 | 0.42 | 0.42 | - | 0.58 | 0.94 | 1.03 | - | 0.78 | 0.68 | 0.55 | 0.47 | 0.38 | 0.15 | 0.21 | 0.31 | 0.17 | 0.14 | 0.08 | 0.03 | 0.28 | 0.25 | 0.17 | - | 0.23 | 0.07 | 0.05 | - | -0.24 | 0.07 | -0.04 | -0.06 | -0.03 | -0.06 | -0.12 | -0.42 | 0.28 | 0.22 | 0.13 | 0.18 | 0.37 | 0.13 | -0.04 | -0.56 | 0.08 | 0.28 | -0.7 | 0.1 | 0.53 | 0.38 | 0.2 | 0.59 | 0.46 |
ROE % |
9.07 | 6.88 | 6.08 | 4.51 | 3.27 | 2.58 | 1.28 | 0.56 | 0.34 | 0.46 | 0.73 | 2.10 | 2.35 | 15.29 | 25.21 | 32.97 | 31.55 | 62.06 | 55.81 | 48.45 | 42.66 | 18.16 | 15.72 | 14.27 | 12.06 | 9.05 | 12.86 | 20.79 | 26.62 | 20.43 | 22.61 | 6.40 | -5.54 | -13.04 | -120.87 | -97.24 | -117.90 | -78.07 | 67.34 | 94.69 | 164.58 | -59.22 | -97.94 | -161.12 | -215.51 | -4.50 | -4.76 | 0.89 | -15.26 | -119.54 | -157.54 | -137.06 | -219.89 | -143.10 | -107.82 | -110.86 | 30.88 | 22.79 | 10.98 | 32.08 | -19.22 | -5.72 |
ROA % |
7.24 | 5.51 | 4.88 | 3.65 | 2.67 | 2.12 | 1.05 | 0.46 | 0.28 | 0.37 | 1.11 | 9.34 | 9.55 | 16.19 | 16.09 | 21.62 | 20.44 | 40.31 | 36.39 | 31.50 | 27.78 | 10.73 | 8.37 | 7.20 | 5.66 | 3.67 | 3.92 | 5.88 | 7.40 | 6.03 | 5.51 | 1.78 | -0.93 | -1.93 | -15.87 | -12.61 | -14.97 | -16.74 | -10.90 | -18.85 | -21.40 | -27.76 | -20.92 | -16.00 | -10.70 | 1.02 | 1.67 | 0.92 | -1.91 | -15.79 | -20.82 | -18.19 | -29.58 | -21.32 | -15.44 | -15.13 | 9.91 | 10.92 | 8.09 | 10.29 | -2.57 | -0.87 |
ROCE % |
7.11 | 5.55 | 4.53 | 2.91 | 3.20 | 2.22 | 0.91 | 0.17 | 0.11 | -0.01 | 0.53 | 2.29 | 2.55 | 15.84 | 27.72 | 36.99 | 35.27 | 45.03 | 39.44 | 30.64 | 23.45 | 26.00 | 24.89 | 24.01 | 22.32 | 12.22 | 17.49 | 27.49 | 35.62 | 33.08 | 41.19 | 28.94 | 21.31 | 21.02 | -69.38 | -71.14 | -89.33 | -74.70 | 34.08 | 69.26 | 118.85 | -71.62 | -76.28 | -75.84 | -82.89 | 118.40 | 102.17 | 63.15 | 18.93 | -84.32 | -126.13 | -106.49 | -196.28 | -113.38 | -80.35 | -88.06 | 23.14 | 39.53 | 47.47 | 3.40 | 20.85 | 16.62 |
DSO |
52.7 | 54.5 | 55.8 | 62.7 | 77.8 | 86.9 | 84.3 | 86.8 | - | 73.7 | 71.1 | 69.6 | - | 35.5 | 25.6 | 49.5 | - | 44.9 | 49.8 | 56.2 | 58.1 | 67.3 | 97.6 | 100.3 | 79.8 | 94.2 | 110.8 | 111.0 | 79.4 | 68.2 | 64.2 | 46.8 | 28.0 | 25.2 | 33.9 | 32.0 | 28.2 | 21.7 | 27.6 | 46.3 | - | 45.8 | 51.6 | 59.8 | - | 52.2 | 51.8 | 53.9 | - | 52.0 | 65.4 | 61.3 | - | 45.3 | 40.7 | 44.6 | - | - | - | 156.2 | - | - |
DIO |
141.3 | 144.9 | 142.9 | 129.1 | 145.3 | 139.1 | 148.1 | 141.0 | - | 134.7 | 137.7 | 122.0 | - | 47.9 | 31.5 | 65.2 | - | 75.1 | 77.2 | 74.9 | 71.2 | 81.3 | 117.8 | 112.2 | 76.1 | 87.5 | 98.5 | 111.0 | 87.4 | 77.7 | 69.8 | 66.9 | 71.3 | 62.5 | 82.8 | 79.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
71.5 | 61.1 | 67.0 | 52.1 | 58.4 | 56.8 | 47.9 | 54.4 | - | 75.1 | 82.9 | 76.4 | - | 33.2 | 19.1 | 41.6 | - | 38.6 | 40.3 | 34.8 | 23.8 | 27.2 | 39.4 | 68.6 | 76.5 | 88.0 | 99.1 | 110.7 | 86.3 | 76.7 | 56.3 | 39.6 | 39.5 | 34.6 | 45.8 | 47.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | 226.0 | 232.4 | 227.8 | - | 208.4 | 208.8 | 191.6 | - | 83.4 | 57.1 | 114.7 | - | 120.0 | 127.0 | 131.2 | 129.3 | 148.6 | 215.3 | 212.5 | 155.8 | 181.7 | 209.3 | 222.0 | 166.8 | 145.9 | 134.0 | 113.7 | 99.3 | 87.7 | 116.7 | 111.0 | 28.2 | 21.7 | 27.6 | 46.3 | - | 45.8 | 51.6 | 59.8 | - | 52.2 | 51.8 | 53.9 | - | 52.0 | 65.4 | 61.3 | - | 45.3 | 40.7 | 44.6 | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | 169.2 | 184.6 | 173.4 | - | 133.3 | 126.0 | 115.2 | - | 50.2 | 38.0 | 73.1 | - | 81.4 | 86.6 | 96.3 | 105.5 | 121.4 | 175.9 | 143.9 | 79.3 | 93.7 | 110.2 | 111.3 | 80.6 | 69.2 | 77.7 | 74.0 | 59.8 | 53.1 | 70.9 | 64.0 | 28.2 | 21.7 | 27.6 | 46.3 | - | 45.8 | 51.6 | 59.8 | - | 52.2 | 51.8 | 53.9 | - | 52.0 | 65.4 | 61.3 | - | 45.3 | 40.7 | 44.6 | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company Advanced Micro Devices, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
Israel
Taiwan
Schweiz
Bermuda
Luxembourg
Niderland
Cayman-islands
